#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary hypophosphataemic rickets Muscular dystrophy Astrocytoma malignant Urea cycle disorder Hormone-dependent prostate cancer Osteopetrosis Alternating hemiplegia of childhood Immunodeficiency Insulinoma Hyperoxaluria Hypertriglyceridaemia Fibrosarcoma Polycythaemia vera Lymphatic malformation Thermal burn More trials…

    Learn about Rare Diseases

    Immunodeficiency congenital – Basic Information Aicardi-Goutieres syndrome – Treatment Congenital nephrogenic diabetes insipidus – Basic Information Rhabdoid tumour Pulmonary sarcoidosis – Life with Disease Synovial sarcoma recurrent – Life with Disease Mucopolysaccharidosis II – Treatment KBG syndrome – Basic Information Hairy cell leukaemia recurrent – Basic Information Leiomyosarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ADMILPARANT Clofazimine Glucose Monohydrate Ph. Eur. Sucrose Naloxone Hydrochloride Meglumine Gadoterate AVTX-009 Wt1/Il15/Il15Ra Mrna Dc Semaglutide Ifosfamide Arbaclofen Censavudine Carvedilol Sodium Sulfate Anhydrous Iobitridol Oleclumab RO7288817 Ondansetron Hydrochloride Elvn-002-1 Quinine Dihydrochloride More therapies…

    Learn about Your Condition

    Sarcoma metastatic Escherichia infection Leukocyte adhesion deficiency Malformation venous Vulvovaginal pruritus Spinal muscular atrophy Sarcoma Rectal cancer stage II Stevens-Johnson syndrome Oropharyngeal cancer recurrent Skin papilloma Sepsis K-ras gene mutation Retinopathy of prematurity Hyperinsulinism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Stomatognathic Diseases

  • Study on High-Dose Vitamin D3 and Glycerol for Improving Wound Healing After Wisdom Tooth Removal in Patients with Vitamin D Insufficiency

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Vitamin D deficiency
    Investigated Drugs:
    • Glycerol
    • Colecalciferol
    Austria

  • Study on Clostridium Botulinum Neurotoxin Type A for Treating Myalgia and Myofascial Pain in Patients with Temporomandibular Disorders

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myofascial pain syndrome
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Sweden

  • Study Comparing Corticosteroid Injection and Arthrocentesis for Temporomandibular Joint Arthritis in Patients Using Methylprednisolone Acetate and Lidocaine Hydrochloride

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Lidocaine Hydrochloride
    • Sodium Chloride
    • Methylprednisolone Acetate
    Sweden

  • Study on Clonazepam for Treating Burning Mouth Syndrome in Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Burning mouth syndrome
    Investigated Drugs:
    • Clonazepam
    Sweden

  • Study on Tranexamic Acid Oral Solution for Preventing Bleeding in Patients on Blood Thinners Undergoing Tooth Extraction

    Recruiting

    3 1
    Investigated Diseases:
    • Gingival bleeding
    • Haemorrhage prophylaxis
    Investigated Drugs:
    • Tranexamic Acid
    Croatia Hungary Romania Spain

  • Study on the Effects of Pentoxifylline, Retinol Acetate, and DL-Alpha Tocopherol Acetate for Patients with Medication-Related Osteonecrosis of the Jaw

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteonecrosis of jaw
    Investigated Drugs:
    • Clindamycin Hydrochloride
    • Dl-Alpha Tocopherol Acetate
    • Pentoxifylline
    France
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!